Literature DB >> 22548004

US Cancer Center Implementation of ASCO/Oncology Nursing Society Chemotherapy Administration Safety Standards.

Saul N Weingart1, Justin W Li, Junya Zhu, Laurinda Morway, Sherri O Stuver, Lawrence N Shulman, Michael J Hassett.   

Abstract

PURPOSE: Because cancer chemotherapy is a high-risk intervention, ASCO and the Oncology Nursing Society (ONS) established in 2009 consensus- and evidence-based national standards for the safe administration of chemotherapy. We sought to assess the implementation status of the ASCO/ONS chemotherapy administration safety standards.
METHODS: A written survey of chemotherapy practices was sent to National Cancer Institute-designated cancer centers. Implementation status of each of 31 chemotherapy administration safety standards was self-reported.
RESULTS: Forty-four (80%) of 55 eligible centers responded. Although the majority of centers have fully implemented at least half of the standards, only four centers reported full implementation of all 31. Implementation varied by standard, with the poorest implementation of standards that addressed documentation of chemotherapy planning, agreed-on intervals for laboratory testing, and patient education and consent before initiation of oral or infusional chemotherapy.
CONCLUSION: Given wide variation in the implementation of ASCO/ONS chemotherapy administration safety standards at US cancer centers, there are significant opportunities for improvement.

Entities:  

Year:  2011        PMID: 22548004      PMCID: PMC3266320          DOI: 10.1200/JOP.2011.000379

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  14 in total

1.  Use of a prospective risk analysis method to improve the safety of the cancer chemotherapy process.

Authors:  Pascal Bonnabry; Laurence Cingria; Monique Ackermann; Farshid Sadeghipour; Lucienne Bigler; Nicolas Mach
Journal:  Int J Qual Health Care       Date:  2005-11-07       Impact factor: 2.038

2.  Error reduction in pediatric chemotherapy: computerized order entry and failure modes and effects analysis.

Authors:  George R Kim; Allen R Chen; Robert J Arceci; Sandra H Mitchell; K Michelle Kokoszka; Denise Daniel; Christoph U Lehmann
Journal:  Arch Pediatr Adolesc Med       Date:  2006-05

3.  Oral chemotherapy safety practices at US cancer centres: questionnaire survey.

Authors:  Saul N Weingart; Jonathan Flug; Daniela Brouillard; Laurinda Morway; Ann Partridge; Sylvia Bartel; Lawrence N Shulman; Maureen Connor
Journal:  BMJ       Date:  2007-01-12

4.  Physician autonomy vs. accountability: making quality standards and medical style mesh.

Authors:  Laurie Larson
Journal:  Trustee       Date:  2007 Jul-Aug

Review 5.  NCCN Task Force Report: Oral chemotherapy.

Authors:  Saul N Weingart; Elizabeth Brown; Peter B Bach; Kirby Eng; Shirley A Johnson; Timothy M Kuzel; Terry S Langbaum; R Donald Leedy; Raymond J Muller; Lee N Newcomer; Susan O'Brien; Denise Reinke; Mark Rubino; Leonard Saltz; Ronald S Walters
Journal:  J Natl Compr Canc Netw       Date:  2008-03       Impact factor: 11.908

6.  Medication errors involving oral chemotherapy.

Authors:  Saul N Weingart; Julio Toro; Justin Spencer; Deborah Duncombe; Anne Gross; Sylvia Bartel; Jeremy Miransky; Ann Partridge; Lawrence N Shulman; Maureen Connor
Journal:  Cancer       Date:  2010-05-15       Impact factor: 6.860

Review 7.  Adherence to therapy with oral antineoplastic agents.

Authors:  Ann H Partridge; Jerry Avorn; Philip S Wang; Eric P Winer
Journal:  J Natl Cancer Inst       Date:  2002-05-01       Impact factor: 13.506

8.  Medication safety in the ambulatory chemotherapy setting.

Authors:  Tejal K Gandhi; Sylvia B Bartel; Lawrence N Shulman; Deborah Verrier; Elisabeth Burdick; Angela Cleary; Jeffrey M Rothschild; Lucian L Leape; David W Bates
Journal:  Cancer       Date:  2005-12-01       Impact factor: 6.860

9.  Improving the cancer chemotherapy use process.

Authors:  D S Fischer; S Alfano; M T Knobf; C Donovan; N Beaulieu
Journal:  J Clin Oncol       Date:  1996-12       Impact factor: 44.544

10.  Chemotherapy safety and severe adverse events in cancer patients: strategies to efficiently avoid chemotherapy errors in in- and outpatient treatment.

Authors:  Anna Markert; Véronique Thierry; Martina Kleber; Michael Behrens; Monika Engelhardt
Journal:  Int J Cancer       Date:  2009-02-01       Impact factor: 7.396

View more
  9 in total

1.  American Society of Clinical Oncology/Oncology Nursing Society chemotherapy safety standards.

Authors:  Mary Gullatte
Journal:  J Oncol Pract       Date:  2013-03       Impact factor: 3.840

2.  Time to get serious about improving the safety of oral chemotherapy.

Authors:  Monika K Krzyzanowska
Journal:  J Oncol Pract       Date:  2013-03       Impact factor: 3.840

3.  Recommendations for the safe use and handling of oral anticancer drugs in community pharmacy: A pan-Canadian consensus guideline.

Authors:  Kathy Vu; Philip Emberley; Erika Brown; Rick Abbott; Justin J Bates; Venetia Bourrier; Kathryn Djordjevic; Julie Greenall; Mova Leung; Mark Pasetka; Louise Paquet; Heather Logan
Journal:  Can Pharm J (Ott)       Date:  2018-05-16

Review 4.  A Systematic Review of Adherence to Oral Antineoplastic Therapies.

Authors:  Joseph A Greer; Nicole Amoyal; Lauren Nisotel; Joel N Fishbein; James MacDonald; Jamie Stagl; Inga Lennes; Jennifer S Temel; Steven A Safren; William F Pirl
Journal:  Oncologist       Date:  2016-02-26

5.  Care of the Elderly Patient on Oral Oncolytics for Advanced Disease.

Authors:  Charles W Given; Barbara A Given
Journal:  Curr Geriatr Rep       Date:  2016-07-25

6.  Patient, provider, and hospital factors associated with oral anti-neoplastic agent initiation and adherence in older patients with metastatic renal cell carcinoma.

Authors:  Deborah R Kaye; Lauren E Wilson; Melissa A Greiner; Lisa P Spees; Jessica E Pritchard; Tian Zhang; Craig E Pollack; Daniel George; Charles D Scales; Chris D Baggett; Cary P Gross; Michael S Leapman; Stephanie B Wheeler; Michaela A Dinan
Journal:  J Geriatr Oncol       Date:  2022-02-04       Impact factor: 3.929

7.  Improving electronic oral chemotherapy prescription: can we build a safer system?

Authors:  Saul N Weingart; Thea Mattsson; Junya Zhu; Lawrence N Shulman; Michael Hassett
Journal:  J Oncol Pract       Date:  2012-09-25       Impact factor: 3.840

8.  Patient Experiences With Oral Chemotherapy: Adherence, Symptoms, and Quality of Life.

Authors:  Jamie M Jacobs; Molly E Ream; Nicole Pensak; Lauren E Nisotel; Joel N Fishbein; James J MacDonald; Joanne Buzaglo; Inga T Lennes; Steven A Safren; William F Pirl; Jennifer S Temel; Joseph A Greer
Journal:  J Natl Compr Canc Netw       Date:  2019-03-01       Impact factor: 11.908

9.  Development of a Smartphone Program to Support Adherence to Oral Chemotherapy in People with Cancer.

Authors:  Xiomara Skrabal Ross; Kate M Gunn; Pandora Patterson; Ian Olver
Journal:  Patient Prefer Adherence       Date:  2019-12-20       Impact factor: 2.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.